134 related articles for article (PubMed ID: 34780792)
21. Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts.
Roberson AE; Hyatt K; Kenkel C; Hanson K; Myers DA
Reprod Sci; 2012 Mar; 19(3):271-81. PubMed ID: 22064385
[TBL] [Abstract][Full Text] [Related]
22. Role of human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C3) in the extrahepatic metabolism of the steroidal aromatase inactivator Formestane.
Wan R; Kong X; Yang Y; Tao S; Chen Y; Teichmann AT; Wieland FH
J Steroid Biochem Mol Biol; 2020 Apr; 198():105527. PubMed ID: 31733346
[TBL] [Abstract][Full Text] [Related]
23. Aldo-Keto Reductase 1C1 (
Michelini S; Chiurazzi P; Marino V; Dell'Orco D; Manara E; Baglivo M; Fiorentino A; Maltese PE; Pinelli M; Herbst KL; Dautaj A; Bertelli M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872468
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers.
Matsunaga T; Hojo A; Yamane Y; Endo S; El-Kabbani O; Hara A
Chem Biol Interact; 2013 Feb; 202(1-3):234-42. PubMed ID: 23165153
[TBL] [Abstract][Full Text] [Related]
25. Structure-based optimization and biological evaluation of human 20α-hydroxysteroid dehydrogenase (AKR1C1) salicylic acid-based inhibitors.
El-Kabbani O; Scammells PJ; Day T; Dhagat U; Endo S; Matsunaga T; Soda M; Hara A
Eur J Med Chem; 2010 Nov; 45(11):5309-17. PubMed ID: 20850205
[TBL] [Abstract][Full Text] [Related]
26. The reactive oxygen species--and Michael acceptor-inducible human aldo-keto reductase AKR1C1 reduces the alpha,beta-unsaturated aldehyde 4-hydroxy-2-nonenal to 1,4-dihydroxy-2-nonene.
Burczynski ME; Sridhar GR; Palackal NT; Penning TM
J Biol Chem; 2001 Jan; 276(4):2890-7. PubMed ID: 11060293
[TBL] [Abstract][Full Text] [Related]
27. Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
Matsumoto R; Tsuda M; Yoshida K; Tanino M; Kimura T; Nishihara H; Abe T; Shinohara N; Nonomura K; Tanaka S
Sci Rep; 2016 Oct; 6():34625. PubMed ID: 27698389
[TBL] [Abstract][Full Text] [Related]
28. The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.
Li W; Hou G; Zhou D; Lou X; Xu Y; Liu S; Zhao X
Oncotarget; 2016 Apr; 7(16):21542-55. PubMed ID: 26934124
[TBL] [Abstract][Full Text] [Related]
29. Molecular docking simulations of steroid substrates into human cytosolic hydroxysteroid dehydrogenases (AKR1C1 and AKR1C2): insights into positional and stereochemical preferences.
Jin Y; Penning TM
Steroids; 2006 May; 71(5):380-91. PubMed ID: 16455123
[TBL] [Abstract][Full Text] [Related]
30. Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling.
Ji Q; Aoyama C; Nien YD; Liu PI; Chen PK; Chang L; Stanczyk FZ; Stolz A
Cancer Res; 2004 Oct; 64(20):7610-7. PubMed ID: 15492289
[TBL] [Abstract][Full Text] [Related]
31. The CCAAT box binding transcription factor, nuclear factor-Y (NF-Y) regulates transcription of human aldo-keto reductase 1C1 (AKR1C1) gene.
Pallai R; Simpkins H; Chen J; Parekh HK
Gene; 2010 Jul; 459(1-2):11-23. PubMed ID: 20338228
[TBL] [Abstract][Full Text] [Related]
32. Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.
Rižner TL; Penning TM
Steroids; 2014 Jan; 79():49-63. PubMed ID: 24189185
[TBL] [Abstract][Full Text] [Related]
33. New enzymatic assay for the AKR1C enzymes.
Beranič N; Stefane B; Brus B; Gobec S; Rižner TL
Chem Biol Interact; 2013 Feb; 202(1-3):204-9. PubMed ID: 23261716
[TBL] [Abstract][Full Text] [Related]
34. Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.
Byrns MC; Jin Y; Penning TM
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):95-104. PubMed ID: 21087665
[TBL] [Abstract][Full Text] [Related]
35. Aldo-keto reductase 1C subfamily genes in skin are UV-inducible: possible role in keratinocytes survival.
Marín YE; Seiberg M; Lin CB
Exp Dermatol; 2009 Jul; 18(7):611-8. PubMed ID: 19320734
[TBL] [Abstract][Full Text] [Related]
36. Long-chain fatty acids inhibit human members of the aldo-keto reductase 1C subfamily.
Hara A; Endo S; Matsunaga T; Soda M; Yashiro K; El-Kabbani O
J Biochem; 2017 Nov; 162(5):371-379. PubMed ID: 28992312
[TBL] [Abstract][Full Text] [Related]
37. Development of potent and selective inhibitors of aldo-keto reductase 1C3 (type 5 17β-hydroxysteroid dehydrogenase) based on N-phenyl-aminobenzoates and their structure-activity relationships.
Adeniji AO; Twenter BM; Byrns MC; Jin Y; Chen M; Winkler JD; Penning TM
J Med Chem; 2012 Mar; 55(5):2311-23. PubMed ID: 22263837
[TBL] [Abstract][Full Text] [Related]
38. Probing the inhibitor selectivity pocket of human 20α-hydroxysteroid dehydrogenase (AKR1C1) with X-ray crystallography and site-directed mutagenesis.
El-Kabbani O; Dhagat U; Soda M; Endo S; Matsunaga T; Hara A
Bioorg Med Chem Lett; 2011 Apr; 21(8):2564-7. PubMed ID: 21414777
[TBL] [Abstract][Full Text] [Related]
39. AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression.
Wei X; Wei Z; Li Y; Tan Z; Lin C
Biochem Genet; 2021 Apr; 59(2):516-530. PubMed ID: 33170398
[TBL] [Abstract][Full Text] [Related]
40. The Interaction of lncRNA XLOC-2222497,
Su T; Yu H; Luo G; Wang M; Zhou C; Zhang L; Hou B; Zhang C; Liu M; Xu D
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370225
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
